Erythrocyte Nitrosothiol Flux and Vasoregulation in Lung

红细胞亚硝基硫醇通量和肺血管调节

基本信息

  • 批准号:
    6839438
  • 负责人:
  • 金额:
    $ 12.14万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-01-01 至 2008-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This proposal describes a five-year plan for the attainment of research skills necessary in the career development of an academic physician-scientist in Critical Care. The candidate is a junior faculty member in an established Division of Pediatric Critical Care and has preliminary research training in pulmonary physiology. The award will be utilized to broaden this background by acquiring a foundation in vascular cell biology and the biochemistry of nitrosative signaling to enable independent investigation of erythrocytic and endothelial communication in the pathobiology of disrupted vasomotor control. Ben Gaston, MD, a leader in pulmonary nitrosothiol signaling research, will serve as primary mentor for the award and Brian Duling, PhD, a pioneer in microcirculation research and vascular cell biology will serve as Co-Mentor. Specific expertise in nitrosative hemoglobin chemistry will be provided by collaboration with investigators from Duke and the University of Pennsylvania. Additionally, an advisory committee of senior scientists will provide scientific and career guidance. Research conducted with this award will investigate the role of the erythrocyte as a link between dysregulated pulmonary blood flow and remote inflammation via nitric oxide (NO) and hemoglobin (Hb) interactions. There is evidence for a nitrosative signaling network in which Hb and NO reactions are balanced to transduce regional redox gradients, coupling oxygen tension and the distribution of NO (and thus flow), in vascular beds. In this regard, we hypothesize oxidative stress in the systemic inflammatory response syndrome (SIRS) may disrupt normal erythrocytic nitrosative signaling and explain dysregulated pulmonary blood flow in this state. We aim, in this project, to determine (1) the degree of abnormal NO loading of RBCs in SIRS, correlating with onset and severity of respiratory failure and (2) to determine the change in Hb vasoactivity in the lung following addition of NO to a beta-chain cysteine (betacys93), the allosteric control of this change, and (3) the endothelial regulation of Hb-based nitrosative signaling. We will pursue these goals on three levels: (1) molecular investigation of intraerythrocytic Hb approximately NO chemistry (2) pharmacologic, immunohistochemical, and proteomic investigations of NO signaling between erythrocytes and endothelial cells in culture, and (3) physiologic correlation of our findings in the isolated murine lung, permitting further transgenic and pharmacologic query. At the conclusion of this project, we expect to define the mechanism of NO traffic between remote vascular beds and the lung via the erythrocyte, as effected by serial transnitrosation reactions. At the conclusion of the development period, the candidate will have acquired skills to pursue further independent investigation of (S)NO and erythrocyte vasoactivity with the hope of informing therapy directed at the dysregulation of regional blood flow in the lung. The candidate's long-term goal is to define the mechanism of NO traffic between regional vascular beds via the erythrocyte, and its role in the evolution of multiple organ failure in severe inflammatory states.
描述(由申请人提供):该提案描述了一项为期五年的计划,以实现重症监护学术医师科学家职业发展所必需的研究技能。该候选人是小儿重症监护阶层既定部门的初级教师,并接受了肺部生理学的初步研究培训。该奖项将通过获得血管细胞生物学的基础和硝化信号传导的生物化学来扩大这种背景,以在干扰血管瘤控制的病理生物学中独立研究红细胞和内皮交流。医学博士本·加斯顿(Ben Gaston)是肺硝基硫醇信号研究的领导者,将担任该奖项的主要导师,而Brian Duling,博士学位,微循环研究的先驱和血管细胞生物学的先驱将担任同事。与杜克大学和宾夕法尼亚大学的调查人员合作将提供硝化血红蛋白化学方面的具体专业知识。此外,高级科学家的咨询委员会将提供科学和职业指导。通过该奖项进行的研究将研究红细胞通过一氧化氮(NO)和血红蛋白(HB)相互作用的肺血流和远程炎症之间的联系。有证据表明,硝化信号网络,其中Hb和无反应在局部氧化还原梯度,耦合氧张力以及NO(因此流动)的分布中,在血管床中平衡。在这方面,我们假设系统性炎症反应综合征(SIR)中的氧化应激可能破坏正常的红细胞硝化信号传导,并解释该状态下肺血流失调。在这个项目中,我们的目标是确定(1)SIRS中RBC的异常NO载荷程度,与呼吸道衰竭的发作和严重程度相关,以及(2)确定在肺链囊cySteine(Betacys93)中添加NO后肺中HB血管活性的变化,该型(Betacys93),noterial noterive no no no no no no no(Betacys93),noterial no no no no no no no no no no no no no n n n n n n n n n n n n no no no no no no no。信号。 We will pursue these goals on three levels: (1) molecular investigation of intraerythrocytic Hb approximately NO chemistry (2) pharmacologic, immunohistochemical, and proteomic investigations of NO signaling between erythrocytes and endothelial cells in culture, and (3) physiologic correlation of our findings in the isolated murine lung, permitting further transgenic and pharmacologic query.在该项目的结论结束时,我们希望通过串行的转硝化反应的影响来定义远程血管床与肺之间无流量的机制。在开发期结束时,候选人将获得对NO和红细胞血管活性的进一步独立研究,以期为肺部区域血流失调的治疗提供信息。候选人的长期目标是通过红细胞来定义区域血管床之间没有交通的机制,及其在严重炎症状态下多器官衰竭演变中的作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ALLAN DOCTOR其他文献

ALLAN DOCTOR的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ALLAN DOCTOR', 18)}}的其他基金

Red blood cell ATP export and transfusion in sepsis
脓毒症中红细胞 ATP 输出和输血
  • 批准号:
    10584768
  • 财政年份:
    2023
  • 资助金额:
    $ 12.14万
  • 项目类别:
ErythroMer: Nanoscale Bio-Synthetic Red Cell Substitute
ErythroMer:纳米级生物合成红细胞替代品
  • 批准号:
    9347784
  • 财政年份:
    2017
  • 资助金额:
    $ 12.14万
  • 项目类别:
SEPSIS-INDUCED RED CELL DYSFUNCTION (SIRD)
脓毒症引起的红细胞功能障碍 (SIRD)
  • 批准号:
    9229050
  • 财政年份:
    2015
  • 资助金额:
    $ 12.14万
  • 项目类别:
SEPSIS-INDUCED RED CELL DYSFUNCTION (SIRD)
脓毒症引起的红细胞功能障碍 (SIRD)
  • 批准号:
    8803196
  • 财政年份:
    2015
  • 资助金额:
    $ 12.14万
  • 项目类别:
SEPSIS-INDUCED RED CELL DYSFUNCTION (SIRD)
脓毒症引起的红细胞功能障碍 (SIRD)
  • 批准号:
    9069918
  • 财政年份:
    2015
  • 资助金额:
    $ 12.14万
  • 项目类别:
SEPSIS-INDUCED RED CELL DYSFUNCTION (SIRD)
脓毒症引起的红细胞功能障碍 (SIRD)
  • 批准号:
    9273245
  • 财政年份:
    2015
  • 资助金额:
    $ 12.14万
  • 项目类别:
Erythrocyte Nitrosothiol Flux and Vasoregulation in Lung
红细胞亚硝基硫醇通量和肺血管调节
  • 批准号:
    6710786
  • 财政年份:
    2004
  • 资助金额:
    $ 12.14万
  • 项目类别:
Erythrocyte Nitrosothiol Flux and Vasoregulation in Lung
红细胞亚硝基硫醇通量和肺血管调节
  • 批准号:
    7350865
  • 财政年份:
    2004
  • 资助金额:
    $ 12.14万
  • 项目类别:
Erythrocyte Nitrosothiol Flux and Vasoregulation in Lung
红细胞亚硝基硫醇通量和肺血管调节
  • 批准号:
    7250307
  • 财政年份:
    2004
  • 资助金额:
    $ 12.14万
  • 项目类别:
Erythrocyte Nitrosothiol Flux and Vasoregulation in Lung
红细胞亚硝基硫醇通量和肺血管调节
  • 批准号:
    7009990
  • 财政年份:
    2004
  • 资助金额:
    $ 12.14万
  • 项目类别:

相似国自然基金

硫化氢抑制采后枸杞乙烯生物合成及其信号转导的机理研究
  • 批准号:
    32360612
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
生物钟核心转录因子PRRs调控JA信号转导及植物对灰霉菌防御的分子机理
  • 批准号:
    32370606
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
基于“丛枝菌根真菌-激素信号转导-转录因子-L/ODC基因”调控路径解析苦参生物碱生物合成的调控机制
  • 批准号:
    82304678
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
组蛋白乙酰化修饰ATG13激活自噬在牵张应力介导骨缝Gli1+干细胞成骨中的机制研究
  • 批准号:
    82370988
  • 批准年份:
    2023
  • 资助金额:
    48.00 万元
  • 项目类别:
    面上项目
新型信号转导光电化学免疫生物传感对肝癌相关分子标志物检测新方法研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    54 万元
  • 项目类别:
    面上项目

相似海外基金

TM INTERACTIONS IN MEMBRANE PROTEIN FOLDING AND FUNCTION
膜蛋白折叠和功能中的 TM 相互作用
  • 批准号:
    7036105
  • 财政年份:
    2006
  • 资助金额:
    $ 12.14万
  • 项目类别:
Regulation of Glucose Transporter Trafficking by Lipids
脂质对葡萄糖转运蛋白运输的调节
  • 批准号:
    6834989
  • 财政年份:
    2005
  • 资助金额:
    $ 12.14万
  • 项目类别:
Characterization of Sacl lipid phosphatases
Sacl 脂质磷酸酶的表征
  • 批准号:
    6965412
  • 财政年份:
    2005
  • 资助金额:
    $ 12.14万
  • 项目类别:
Bacteria-Epithelial Cell Cytoskeleton Interaction
细菌-上皮细胞细胞骨架相互作用
  • 批准号:
    6921030
  • 财政年份:
    2005
  • 资助金额:
    $ 12.14万
  • 项目类别:
Regulation of Glucose Transporter Trafficking by Lipids
脂质对葡萄糖转运蛋白运输的调节
  • 批准号:
    7026385
  • 财政年份:
    2005
  • 资助金额:
    $ 12.14万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了